Cencora Inc. (COR) stock news · P/E 25, rev $321.33B
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
This COR news page leads with what Cencora Inc. filed — not a scraped headline mill.
No cached 8-K sentence for COR yet. We will not pad this page with generic market recap.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.55B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 25.3.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the COR stock page; for the tape open the quote page.
COR stock news FAQ
What are COR's latest revenue and net income?
Latest cached Cencora Inc. (COR) revenue for Sep 30, 2025 was $321.33B. Net income was $1.55B. Statements: https://lician.com/financials/cor
How did COR revenue change from the prior cached period?
Cached Cencora Inc. (COR) revenue was up 9.3% from $293.96B (Sep 30, 2024) to $321.33B (Sep 30, 2025). Statements: https://lician.com/financials/cor
What is COR's P/E ratio?
Cencora Inc. (COR) trailing P/E is 25.3 on the latest cached fundamentals snapshot.
What is COR's market cap?
Cencora Inc. (COR) market cap is $53.91B on the latest cached fundamentals snapshot.
What kind of company is COR?
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Where is COR stock news listed?
Cached stock news for Cencora Inc. (COR) is listed at https://lician.com/news/cor. Filings: https://lician.com/sec/cor
Not investment advice.